ProCE Banner Activity

HIV Care During COVID-19 in México: Challenges and Solutions

Clinical Thought
How can HIV clinics in resource-limited settings overcome challenges posed by the COVID-19 pandemic? Dr. Luis E. Soto-Ramirez provides insights on strategies his institution has implemented to maintain his patients’ trust and engagement.

Released: December 09, 2020

Expiration: December 08, 2021

No longer available for credit.

Share

Faculty

Luis E. Soto-Ramirez

Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

Supporters

Este programa cuenta con una subvención educativa de

ViiV Healthcare

Faculty Disclosure

Primary Author

Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

Luis E. Soto-Ramirez, MD, has disclosed that he has received consulting fees from Gilead Sciences, GlaxoSmithKline, Merck, and ViiV Healthcare and fees for non-CME/CE services from Gilead Sciences, Janssen, and Merck.